BeCRO is actively representing its members towards the other stakeholders, being the pharmaceutical, biotechnology and medical device industry, the regulatory authorities, the investigational sites and last but not least the patients.
Discover here where and how we represented our members.
BeCRO members can participate in EUCROF Webinars and Trainings at reduced cost. Please visit the link below to find the latest information. The code for the fee reduction can be requested via admin@becro.be https://www.eucrof.eu/webinars
Read More "EUCROF Webinars and Trainings"On 30 September 2020, the Working group Informed Consent published version 1.0 of the guidance document on the use of e-consent in Belgium. Please find hereby the link to the document: https://overlegorganen.gezondheid.belgie.be/sites/default/files/content/guidance_on_use_of_e-icf_vf.pdf
Read More "GUIDANCE FOR SPONSORS ON THE USE OF ELECTRONIC INFORMED CONSENT IN INTERVENTIONAL CLINICAL TRIALS IN BELGIUM"Please note that this document is to be read in conjunction with the latest version of the European guidance and that the national guidance provides some more detailed clarifications and additional topics of interest. This text was written by the FAMHP, the Clinical Trial College and the Belgian association of Research Ethics Committees (BAREC).The information […]
Read More "On 30th April, FAMHP published V2 of the Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic"On 25th March, EMA issued a draft guidance for consultation with deadline for comments on 25th April. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf
Read More "Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials"On 28th of April, The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published version 3 of their guidance to sponsors on how to manage clinical trials during the COVID-19 (Coronavirus) pandemic. Key changes from v2 (27-03-2020): distributor to trial participant IMP shipment, monitoring, remote source data verification […]
Read More "Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic"The BeCRO board is looking forward to celebrate its 10th anniversary together with ACRON celebrating its 25th anniversary at the EUCROF conference in 2020! ORGANIZERS: EUCROF AFCRO BECRO DATE: FEBRUARY 10, 2020 – FEBRUARY 11, 2020
Read More "SAVE THE DATE! JOINED EUCROF, ACRON & BECRO 5TH EUROPEAN CONFERENCE ON CLINICAL RESEARCH"Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019 Date & Time: 17 April 2019 from 3:30 PM to 5:00 PM (CET) Attendance Fee: € 90,- for EUCROF non-members € 60,- for EUCROF members using the code DATA0417 Register here
Read More "Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019"SAVE THE DATES BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY ? * June 21, 2019 BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY? Blockchain in Clinical Trials- How and Why Blockchain and Distributed Ledger Technologies (DLTs) are new disruptive approaches in the Clinical Trials Industry? For the last 2 years, multiple initiatives are moving […]
Read More "BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY?"Direct to Patient (D2P) shipment for Clinical Trials – Survey Dear Sponsor, CRO, Investigator or Patient, Within Europe and more specifically within Belgium, Direct To Patient (D2P) shipments have limitations within the current regulatory framework. Considering the growing enthusiasm of pharma companies, investigators and patients performing D2P shipments in the US, we need to investigate […]
Read More "Direct to Patient (D2P) shipment for Clinical Trials – Survey"Virtual Clinical Trials and Direct to Patient Shipments BeCRO has set up and coordinates, with the cabinet of Maggie De Block, FAMHP, FlandersBio, BioWin, Lifetech Brussels, BRAS and several top Pharma companies, a lobbying group on “Virtual Clinical trials and Direct to Patient Shipments”. This working group has conducted a survey on Direct to Patient […]
Read More "Virtual Clinical Trials and Direct to Patient Shipments"